Pfizer Inc. (PFE) Free cash flow 2016–2025
Pfizer Inc. (PFE) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$9.1BFY2025 · since FY2016: $14.4B → $9.1B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $9.1B | -7.7% |
| FY2024 | $9.8B | +105.2% |
| FY2023 | $4.8B | -81.6% |
| FY2022 | $26.0B | -12.8% |
| FY2021 | $29.9B | +145.3% |
| FY2020 | $12.2B | +15.5% |
| FY2019 | $10.5B | -23.8% |
| FY2018 | $13.8B | -6.8% |
| FY2017 | $14.8B | +3.3% |
| FY2016 | $14.4B | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice